d.ndiaye

TL2 Moderator · Bologna

Contributes reviews on supplier material. Based in Bologna.

Joined 9 April 2025 · last posted 2d

80 posts, newest first. Showing up to 150.

Reflectance and photometric devices: precision in practice — a second dataset Replied, post #82 · Analytics › Home & field testing · 26 Jul 2026 · 0 likes post #81 answers the question as asked. The question underneath it is different. Immunoassay limitations: tests that use antibodies have cross-reactivity limitations.…
Shoulders, tangent skims, and defensible integration Replied, post #20 · Analytics › HPLC & UHPLC · 24 Jul 2026 · 33 likes Picking up post #17: that is the part I would want checked first. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the…
Tracking a shortage from primary sources rather than rumour Replied, post #114 · Access › Shortages · 21 Jul 2026 · 8 likes Communication from suppliers: a supplier having supply problems usually communicates them. If a supplier goes silent, that is itself information.
Muscle cramps: the ordinary causes before the exotic ones — a second dataset Replied, post #62 · Practice › Side effects · 20 Jul 2026 · 17 likes Vomiting: when it is expected (first-dose reactions or early titration) and when it is a reason to stop and seek help are different. Occasional vomiting during…
Impurity thresholds: where the common numbers come from Replied, post #2 · Analytics › Impurities & related substances · 10 Jul 2026 · 10 likes Related substances: compounds chemically related to the target peptide but not the target peptide itself. The standard method separates them and reports them as area…
[2026 update] Travelling with an injectable: documentation and practicalities Replied, post #67 · Access › International · 9 Jul 2026 · 14 likes I read post #65 twice before replying, because I had assumed the opposite. Travel with medication: carrying a compound across borders is complicated by legal status.…
Coming back to: A structured critique template this community uses Replied, post #52 · Evidence › Study critique · 7 Jul 2026 · 14 likes This follows post #49 rather than contradicting it. Multiple comparisons: if a paper reports many outcomes, the chance of a spurious association by random chance is…
How much context is too much context in a first post? Replied, post #34 · Start Here › How to Ask · 7 Jul 2026 · 21 likes On post #30 — agreed on the reasoning, with one qualification. Asking a follow-up: new topic or reply in the old one? If the answer depends on the previous post, reply.…
Coming back to: Why a preprint's supplementary material is often the best part Replied, post #95 · Evidence › Preprints · 3 Jul 2026 · 12 likes Coming back to post #93, because the follow-up matters more than the original answer. Server repositories: medRxiv for medicine, bioRxiv for biology. Preprints on these…
Coming back to: Time to steady state after a dose increase Replied, post #91 · Pharmacology › Pharmacokinetics · 2 Jul 2026 · 30 likes Bioavailability: oral semaglutide has low bioavailability (roughly 1%) due to peptide instability. That is why the oral dose (14 mg) is so much larger than the…
Restarting after a long gap: what the labelling implies Replied, post #8 · Practice › Dosing & titration · 1 Jul 2026 · 31 likes I read post #6 twice before replying, because I had assumed the opposite. Holding a dose indefinitely: the trials did not study indefinite holding at a non-maximum…
0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #82 · Devices › Syringes & needles · 23 Jun 2026 · 28 likes Needle gauge: smaller numbers (30G) are finer and less painful. Larger numbers (25G) are courser. For subcutaneous injection, 27-30G is typical. Finer needles take…
CJC-1295 with and without DAC: what the modification does Replied, post #90 · Compounds › Secretagogues & GH axis · 21 Jun 2026 · 8 likes IGF-1 as a surrogate: it is a better integrated measure than a spot growth hormone level and it is still a surrogate, with all the caveats that come with surrogates.…
A structured critique template this community uses — a second dataset Replied, post #12 · Evidence › Study critique · 17 Jun 2026 · 0 likes Defending a paper against criticism: if the authors respond, they might clarify something the paper explained poorly. Their response might also miss your point. Either…
Injecting into an area that has become firm: why not to Replied, post #63 · Practice › Administration · 13 Jun 2026 · 6 likes Cold solution and stinging: warming the vial in your hands for a minute before injection reduces the stinging sensation substantially. This is the simplest thing to try…
Insurance and replacement policies, compared Replied, post #9 · marked as the solution · Sourcing › Logistics · 8 Jun 2026 · 9 likes This follows post #6 rather than contradicting it. Documentation after arrival: photograph the parcel and its contents on arrival. If something later turns out wrong…
Reading U-100 graduations, with a conversion table Replied, post #31 · Devices › Syringes & needles · 3 Jun 2026 · 12 likes Needle length: typical lengths for subcutaneous injection are 4-6 mm (short), 8 mm (standard), or 10-12 mm (longer). Longer needles are needed for deeper tissue or if…
Comparing prices across jurisdictions without misleading yourself Replied, post #23 · Access › Pricing · 31 May 2026 · 6 likes Pharmacy acquisition cost: a pharmacy pays less than the patient pays, even at insurance rates. That margin is where the pharmacy's costs and profit live.
A parcel stationary at a customs facility for nine days — does this still hold? Replied, post #23 · Sourcing › Logistics · 26 May 2026 · 0 likes Customs outcomes are not predictable at the level of an individual parcel. What is predictable is that consistent, accurate declarations correlate with fewer…
Journal club: LEADER as the historical anchor Replied, post #76 · Evidence › Journal club · 19 May 2026 · 0 likes PIONEER 6 (N Engl J Med 2019): Cardiovascular safety trial for oral semaglutide, not efficacy. Non-inferiority for safety was met. The trial was not designed to…
Journal club: orforglipron phase 2 and the non-peptide question Replied, post #64 · Evidence › Journal club · 15 May 2026 · 3 likes SURPASS-2 (N Engl J Med 2021): Direct comparison of tirzepatide with semaglutide 1.0 mg. The 1.0 mg dose is not the highest available, which is the central and…
Prescription requirements and telehealth models — a second dataset Replied, post #29 · Sourcing › Regulatory · 14 May 2026 · 0 likes Labelling and intended use: a compound sold as "research-use-only" does not change its pharmacology if ingested. It changes the legal status of the sale. The labelling…
Semaglutide and gastric emptying — the mechanism behind most of the side-effect profile Replied, post #25 · Compounds › Semaglutide · 13 May 2026 · 24 likes Picking up post #22: that is the part I would want checked first. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the…
[2026 update] Storing lyophilised material long term: what governs the shelf life Replied, post #110 · Practice › Storage & stability · 5 May 2026 · 3 likes Container choice matters: the material of the vial, the rubber closure, the fill volume all affect how quickly the contents degrade. Smaller fill volumes lose less to…
Citation sweep results: how many references did not say what was claimed Replied, post #83 · Meta › Wiki maintenance · 24 Apr 2026 · 31 likes post #82 is right about the mechanism and I think understates the practical bit. I disagree with the reply above, and I think the disagreement is substantive rather…
Spike-and-recover accuracy for a peptide assay Replied, post #58 · Analytics › Method validation · 9 Apr 2026 · 0 likes post #57 answers the question as asked. The question underneath it is different. System suitability: injections run at the start of a batch to establish that the…
Follow-up: Request: a per-category review queue Replied, post #3 · Meta › Feature requests · 29 Mar 2026 · 26 likes post #2 is right about the mechanism and I think understates the practical bit. Tradeoffs: every feature has a cost in maintenance and complexity. Acknowledging…
Air bubbles in a subcutaneous injection: the honest risk assessment — does this still… Replied, post #27 · Practice › Administration · 25 Mar 2026 · 9 likes Air bubbles in a subcutaneous injection: the honest risk assessment is low. Tiny air bubbles in subcutaneous tissue do not behave like an air embolism in a blood…
What a good consultation looks like from the other side Replied, post #23 · Clinical › Prescriber conversations · 12 Mar 2026 · 30 likes post #22 is right about the mechanism and I think understates the practical bit. Preparing for an appointment: bring recent bloodwork, a list of current medications…
The lowest dose that does anything: is that a real question? Replied, post #100 · Practice › Dosing & titration · 7 Mar 2026 · 27 likes Dose equivalence between different incretin analogues is a weak concept. The molecules differ in structure, half-life, receptor selectivity, and in what has been…
Revisiting: Journal club: SURMOUNT-1, read without the press release Replied, post #21 · Evidence › Journal club · 27 Feb 2026 · 9 likes Session format: read the paper before posting. The discussion is much better when everyone has. Start with the estimand and population, then methods, then results, then…
Mass error in ppm: the arithmetic and the caveat Replied, post #123 · Analytics › Mass spectrometry · 16 Feb 2026 · 4 likes Quantitation by MS: most quantitation is done by LC-UV detection at 214 nm, not by MS, because extinction coefficients are better known. MS can quantify if an internal…
Pharmacy supply in the UK and the questions you will be asked Replied, post #33 · Regional › UK & Ireland · 7 Feb 2026 · 31 likes MHRA is the regulator. Licensed incretin analogues are prescription-only medicines. NHS and private prescribing routes exist with materially different access criteria…
Coming back to: Reading a supplier's product description as a marketing document Replied, post #5 · Compounds › Other compounds · 24 Jan 2026 · 8 likes This subcategory exists because some people will research compounds outside the main groups discussed here. The standard of evidence and honesty about its limits…
Storing lyophilised material long term: what governs the shelf life Replied, post #22 · Practice › Storage & stability · 11 Jan 2026 · 0 likes Worth separating two things that post #18 runs together. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did…
Distinguishing expected GI effects from something that needs urgent attention Replied, post #30 · Practice › Side effects · 4 Jan 2026 · 33 likes Gallbladder complications: rapid weight loss increases the risk of gallstone formation. The mechanism is not specific to this drug class. The risk is greatest in the…
Reverse causation in a cohort study of weight and outcome Replied, post #13 · Evidence › Study critique · 2 Jan 2026 · 11 likes I read post #11 twice before replying, because I had assumed the opposite. What makes a methodological criticism substantive: it identifies a specific feature of the…
What "verified" means on our vendor pages, stated narrowly Replied, post #13 · Sourcing › Vendor reports · 27 Dec 2025 · 0 likes Pattern across lots: a single result is a data point. Three or four results from the same supplier showing a consistent pattern becomes a record worth discussing. Two…
Robustness: the parameters worth deliberately varying Replied, post #46 · Analytics › Method validation · 6 Dec 2025 · 12 likes This follows post #43 rather than contradicting it. Linearity: the detector response is proportional to compound concentration across the working range. Demonstrated by…
A widely repeated interaction claim that turns out to be unsupported Replied, post #9 · Practice › Interactions · 3 Dec 2025 · 10 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
Why "any advice?" is the least effective ending for a post — the long version Replied, post #82 · Start Here › How to Ask · 7 Nov 2025 · 1 like I read post #80 twice before replying, because I had assumed the opposite. Avoid "any advice?" at the end. It is so generic that people do not know which part of the…
EMA product information as a primary source Replied, post #17 · Regional › European Union · 30 Oct 2025 · 18 likes Private prescription with self-payment is legal across the EU and is the common route where public reimbursement is not available.
Coming back to: Why quantitation is the hard part, not detection Replied, post #83 · Analytics › Home & field testing · 23 Oct 2025 · 14 likes What you can use home tests for: confirmation that a solution contains peptide (as opposed to being saline alone), rough screening for very different compounds…
Liver enzymes drifting down and what that usually means Replied, post #21 · Clinical › Bloodwork · 23 Oct 2025 · 29 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
What happens after your first post: likes, trust levels, and why none of it matters much… Replied, post #66 · Start Here › Welcome · 18 Oct 2025 · 28 likes This follows post #63 rather than contradicting it. Marked solutions are the site's way of saying that someone asked a good question and someone else gave an answer…
Reverse causation in a cohort study of weight and outcome — a second dataset Replied, post #21 · Evidence › Study critique · 13 Sep 2025 · 1 like Worth separating two things that post #17 runs together. Building consensus on which criticisms matter: if everyone agrees that the sample size is small but only you…
Power cut for eleven hours: how I assessed it afterwards Replied, post #48 · Practice › Storage & stability · 7 Sep 2025 · 0 likes Visual inspection: if a solution is visibly cloudy, discoloured, or contains particles, those are red flags. Faint opalescence or minor colour shift may be normal but…
[2026 update] Does dual agonism explain the effect size, or is it dose? Replied, post #11 · Compounds › Tirzepatide · 2 Sep 2025 · 0 likes Worth separating two things that post #7 runs together. Storage and stability: published data on licensed tirzepatide formulations exists and is worth reading directly…
Coming back to: Resolution and tailing factor: real acceptance criteria Replied, post #51 · Analytics › HPLC & UHPLC · 29 Aug 2025 · 29 likes Peak purity: a diode-array detector records a spectrum at every time point. If a peak contains two co-eluting species with different spectra, the spectrum changes…
Reading a rodent study on a secretagogue without over-extrapolating Replied, post #39 · Compounds › Secretagogues & GH axis · 23 Aug 2025 · 16 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
Which panel is worth repeating and which is worth ignoring Replied, post #89 · Clinical › Bloodwork · 20 Aug 2025 · 6 likes Analytical imprecision: any measurement has an error margin. A small difference in consecutive tests is usually measurement noise, not a real change. Knowing the…
What a documentation review can and cannot tell you Replied, post #75 · Sourcing › Independent verification · 16 Aug 2025 · 0 likes Cost and turnaround: different services have different pricing and turnaround times. Janoshik's turnaround is weeks by mail; VendorInvestigate documentation review is…
Follow-up: Glucagon receptor agonism in a weight-loss compound Replied, post #3 · Pharmacology › Receptor biology · 29 Jul 2025 · 0 likes Glucagon receptor agonism: glucagon receptor agonism increases energy expenditure and promotes hepatic fat oxidation. The mechanism is distinct from GLP-1 and GIP…
Revisiting: Reading a denial letter as a specification for your appeal Replied, post #41 · Access › Insurance & coverage · 11 Jul 2025 · 1 like Generic versus brand: most of these compounds do not have generic versions yet. Once they do, formulary coverage and pricing will shift.
Forced degradation studies: designing one that is informative — does this still hold? Replied, post #29 · Analytics › Method validation · 2 Jul 2025 · 0 likes Limits of detection and quantitation: LOD is the lowest concentration that produces a signal above background. LOQ is the lowest concentration at which the method meets…
BPC-157: what the rodent literature actually shows, and what it does not — a second… Replied, post #64 · Compounds › Repair & healing peptides · 30 Jun 2025 · 13 likes Why plausible mechanism is not evidence of effect: a mechanism that is chemically or biologically plausible can fail in practice for dozens of reasons —…
[2026 update] An appeal that failed, and what I would do differently Replied, post #108 · Access › Insurance & coverage · 14 Jun 2025 · 2 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
Coming back to: Getting a referral rather than a refusal Replied, post #65 · Clinical › Prescriber conversations · 13 Jun 2025 · 2 likes This follows post #62 rather than contradicting it. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still…
Follow-up: Tracking intake honestly when appetite is absent Replied, post #51 · Nutrition & Training › Protein & intake · 9 Jun 2025 · 12 likes post #50 answers the question as asked. The question underneath it is different. I disagree with the reply above, and I think the disagreement is substantive rather…
Splitting a vial for two laboratories: how to do it without ruining both Replied, post #56 · Sourcing › Independent verification · 7 Jun 2025 · 2 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
Checking someone else's arithmetic: a worked example thread Replied, post #46 · Practice › Reconstitution · 10 May 2025 · 0 likes Picking up post #43: that is the part I would want checked first. For anyone arriving from a search: the marked solution above is the direct answer, and the replies…
[2026 update] US compounding rules and how they changed Replied, post #12 · Regional › North America · 8 May 2025 · 0 likes Compounding pharmacies: pharmaceutical compounding of a drug not on the FDA shortage list is substantially constrained. The landscape changed when supply normalised.…
A well-designed study with a badly written abstract Replied, post #59 · Evidence › Study critique · 3 May 2025 · 0 likes Coming back to post #57, because the follow-up matters more than the original answer. Defending a paper against criticism: if the authors respond, they might clarify…
Second pass at: Retatrutide mass and identity: what a report should show Replied, post #33 · Compounds › Retatrutide · 1 May 2025 · 7 likes Picking up post #30: that is the part I would want checked first. Triple agonism: is the effect additive, synergistic, or neither? A phase 2 comparison of tirzepatide…
Second pass at: Triple agonism: additive, synergistic, or neither? Replied, post #26 · Compounds › Retatrutide · 17 Mar 2025 · 1 like Glucagon receptor agonism seems paradoxical in a weight-loss compound because glucagon raises blood glucose. The paradox resolves because glucagon agonism also…
Journal club: SURMOUNT-4 and continuation versus withdrawal — a second dataset Replied, post #3 · Evidence › Journal club · 14 Mar 2025 · 5 likes FLOW (N Engl J Med 2024): Semaglutide renal outcomes in type 2 diabetes and chronic kidney disease. Stopped early for efficacy. Component-by-component analysis is…
Adducts: sodium, potassium, and the peak you did not expect Replied, post #14 · Analytics › Mass spectrometry · 19 Feb 2025 · 1 like Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
When "no data" is the complete and final answer Replied, post #95 · Compounds › Other compounds · 17 Feb 2025 · 2 likes Worth separating two things that post #91 runs together. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather…
Introducing myself and asking whether my planned first topic belongs anywhere Replied, post #3 · Start Here › Welcome · 5 Feb 2025 · 17 likes Welcome. The orientation materials are pinned at the top of this category and they take about an hour. They answer most of the questions a new member has and they save…
Escalating every six weeks instead of four: what I observed over eight months Replied, post #30 · Practice › Dosing & titration · 22 Jan 2025 · 1 like post #29 is right about the mechanism and I think understates the practical bit. Titrating on tolerability rather than on the calendar: some people escalate when they…
Oral semaglutide bioavailability and its variability between people — a second dataset Replied, post #81 · Compounds › Oral incretins · 27 Dec 2024 · 15 likes Worth separating two things that post #77 runs together. Why an oral formulation is a formulation achievement: the molecule is the same but the tablet is novel. Getting…
Follow-up: Tirzepatide's shorter half-life and its one practical consequence Replied, post #101 · Compounds › Tirzepatide · 21 Dec 2024 · 0 likes Half-life difference: tirzepatide is about 5 days versus semaglutide's week-long. Practically, that means steady state is reached slightly faster and the post-dose…
Reporting a good result: why nobody bothers and why they should — one year on Replied, post #6 · Sourcing › Vendor reports · 16 Nov 2024 · 25 likes On post #2 — agreed on the reasoning, with one qualification. Blind submission is worth the effort: have someone else relabel the sample so neither you nor the…
Choosing which test to pay for, given a fixed budget — does this still hold? Replied, post #19 · Sourcing › Independent verification · 4 Nov 2024 · 0 likes When results are inconclusive: if a testing service reports "insufficient to verify" on a documentation review, that is not a negative finding about the product. It…
Meeting a protein target on a suppressed appetite — one year on Replied, post #10 · Nutrition & Training › Protein & intake · 12 Sep 2024 · 0 likes Picking up post #7: that is the part I would want checked first. For anyone arriving from a search: the marked solution above is the direct answer, and the replies…
Follow-up: Where the four-week escalation interval comes from, and what it is not Replied, post #41 · Practice › Dosing & titration · 8 Aug 2024 · 9 likes Splitting a weekly dose in two: the pharmacokinetic argument against is that you want the benefit of long half-life, which gives a slowly changing plasma level from a…
Guidelines revision: what changed and why Replied, post #115 · Meta › Announcements · 28 Jul 2024 · 16 likes Feedback to announcements: if you have feedback on an announced change (not a question, but your position) post it in the Meta category rather than here.
Follow-up: Conditions that change the calculus rather than forbidding it Replied, post #26 · Safety › Contraindications · 23 Jul 2024 · 0 likes I read post #24 twice before replying, because I had assumed the opposite. Concurrent insulin or sulfonylureas: not an absolute contraindication but requires dose…
Second pass at: Retatrutide dose escalation in the published trials Replied, post #59 · Compounds › Retatrutide · 20 Jul 2024 · 1 like The phase 2 obesity paper reported dose-dependent weight reduction of a magnitude that attracted attention. It also reported dose-dependent heart-rate increases. The…
Oral contraceptives and delayed emptying: what the data shows Replied, post #13 · Practice › Interactions · 7 Jul 2024 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…